Literature DB >> 8845710

Carbamazepine for combativeness in acute traumatic brain injury.

P E Chatham-Showalter1.   

Abstract

Psychiatrists increasingly consult on the treatment of acute traumatic brain injury (TBI) when combativeness compromises safe critical care. The author discusses use of carbamazepine for 7 combative patients with multiple trauma including TBI. This cohort had a clinical decrease in combativeness within 4 days after carbamazepine, compared with this Level I trauma center's experience of prolonged combative periods without its use.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8845710     DOI: 10.1176/jnp.8.1.96

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  3 in total

Review 1.  The use of newer anticonvulsants in neuropsychiatric disorders.

Authors:  Edward Kim
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

2.  Neuropsychiatric Aspects of Traumatic Brain Injury.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-03       Impact factor: 3.972

3.  Pharmacological interventions for agitated behaviours in patients with traumatic brain injury: a systematic review.

Authors:  David Williamson; Anne Julie Frenette; Lisa D Burry; Marc Perreault; Emmanuel Charbonney; Francois Lamontagne; Marie-Julie Potvin; Jean-Francois Giguère; Sangeeta Mehta; Francis Bernard
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.